Mylan Laboratories Inc. Interested in Merck KGaA Drug Unit

February 28, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON/FRANKFURT, Feb 28 (Reuters) - U.S.-based Mylan Laboratories Inc is interested in bidding for Merck KGaA's generics business, joining a growing of band of firms lining up offers, people familiar with the situation said on Wednesday.

>>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Europe